Jia Wang

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Regulatory T Cells

Interstitial Lung Disease

Rheumatoid Arthritis

Top Venues

Journal of immunology research

Therapeutic advances in chronic disease

Therapeutic advances in musculoskeletal disease

This page only lists publications with an associated author ORCID identifier.

Publications

Jia Wang, Hong-Xia Guo, Ting Cheng, Lei Shi, Sheng-Xiao Zhang, Xiao-Feng Li
Reduced circulating Tregs and positive pANCA were robustly associated with the occurrence of antiphospholipid syndrome in patients with systemic lupus erythematosus. Lupus (2023)
Sheng-Xiao Zhang, Jia Wang, Cai-Hong Wang, Rui-Huan Jia, Ming Yan, Fang-Yuan Hu, Guang-Ying Liu, Xue-Yu Liu, Jing Luo, Chong Gao, Xiao-Feng Li
Low-dose IL-2 therapy limits the reduction in absolute numbers of circulating regulatory T cells in rheumatoid arthritis. Therapeutic advances in musculoskeletal disease 13 (2021)
Jia Wang, Sheng-Xiao Zhang, Yu-Fei Hao, Meng-Ting Qiu, Jing Luo, Yu-Yao Li, Chong Gao, Xiao-Feng Li
The numbers of peripheral regulatory T cells are reduced in patients with psoriatic arthritis and are restored by low-dose interleukin-2. Therapeutic advances in chronic disease 11 (2020)
Lei Shi, Xiao-Lei Han, Hong-Xia Guo, Jia Wang, Yu-Ping Tang, Chong Gao, Xiao-Feng Li
Increases in tumor markers are associated with primary Sjögren's syndrome-associated interstitial lung disease. Therapeutic advances in chronic disease 11 (2020)
Na-Lin Lai, Sheng-Xiao Zhang, Jia Wang, Jia-Qian Zhang, Cai-Hong Wang, Chong Gao, Xiao-Feng Li
The Proportion of Regulatory T Cells in Patients with Ankylosing Spondylitis: A Meta-Analysis. Journal of immunology research 2019 (2019)
Hong-Yan Wen, Jia Wang, Sheng-Xiao Zhang, Jing Luo, Xiang-Cong Zhao, Chen Zhang, Cai-Hong Wang, Fang-Yuan Hu, Xiao-Juan Zheng, Ting Cheng, Hong-Qing Niu, Guang-Ying Liu, Wen-Xian Yang, Na-Na Yu, Jin-Li Ru, Qi-Xiang Chen, Xue-Chun Lu, Pei-Feng He, Chong Gao, Xiao-Feng Li
Low-Dose Sirolimus Immunoregulation Therapy in Patients with Active Rheumatoid Arthritis: A 24-Week Follow-Up of the Randomized, Open-Label, Parallel-Controlled Trial. Journal of immunology research 2019 (2019)